Cite
HARVARD Citation
Smith, P. et al. (2022). Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. Journal of Crohn's and colitis. pp. 1436-1446. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smith, P. et al. (2022). Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. Journal of Crohn's and colitis. pp. 1436-1446. [Online].